Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Jan;11(1):53–56. doi: 10.1111/j.1365-2125.1981.tb01101.x

Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694.

H A Davies, J Rhodes, M Thomas
PMCID: PMC1401681  PMID: 7213509

Abstract

1 The effect on gastric acid secretion of a mast cell stabiliser FPL-52694 was examined in nine healthy volunteers. 2 The compound which is moderately well absorbed after oral ingestion, was taken for 5 days prior to the measurement of acid secretion and was also given intravenously during part of the gastric test. A submaximal dose of pentagastrin (0.3 microgram/kg/h) was given by intravenous infusion for 2 h in a controlled test and then after administration of FPL-52694. 3 There was a significant reduction (37%) in acid secretion during the second test which was probably due to the effect of the compound on mast cell degranulation in the gastric mucosa.

Full text

PDF
53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aadland E., Berstad A. Effect of cimetidine on histamine- and pentagastrin-stimulated gastric secretion in healthy subjects. Scand J Gastroenterol. 1979;14(3):367–372. doi: 10.3109/00365527909179898. [DOI] [PubMed] [Google Scholar]
  2. Blair H., Herbert R. L. Treatment of seasonal allergic rhinitis with 2 percent sodium cromoglycate (BP) solution. Clin Allergy. 1973 Sep;3(3):283–288. doi: 10.1111/j.1365-2222.1973.tb01335.x. [DOI] [PubMed] [Google Scholar]
  3. Dannaeus A., Foucard T., Johansson S. G. The effect of orally administered sodium cromoglycate on symptoms of food allergy. Clin Allergy. 1977 Mar;7(2):109–115. doi: 10.1111/j.1365-2222.1977.tb01431.x. [DOI] [PubMed] [Google Scholar]
  4. Hassan M. A., Hobsley M. Positioning of subject and of nasogastric tube during a gastric secretion study. Br Med J. 1970 Feb 21;1(5694):458–460. doi: 10.1136/bmj.1.5694.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heatley R. V., Calcraft B. J., Rhodes J., Owen E., Evans B. K. Disodium cromoglycate in the treatment of chronic proctitis. Gut. 1975 Jul;16(7):559–563. doi: 10.1136/gut.16.7.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howell J. B., Altounyan R. E. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet. 1967 Sep 9;2(7515):539–542. doi: 10.1016/s0140-6736(67)90499-0. [DOI] [PubMed] [Google Scholar]
  7. Ogle C. W., Lau H. K. Disodium cromoglycate: a novel gastric antiulcer agent? Eur J Pharmacol. 1979 May 15;55(4):411–415. doi: 10.1016/0014-2999(79)90117-1. [DOI] [PubMed] [Google Scholar]
  8. Soll A. H. The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells. J Clin Invest. 1978 Feb;61(2):370–380. doi: 10.1172/JCI108947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Soll A. H. The interaction of histamine with gastrin and carbamylcholine on oxygen uptake by isolated mammalian parietal cells. J Clin Invest. 1978 Feb;61(2):381–389. doi: 10.1172/JCI108948. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES